Jump to content

Peter Lehmann (author): Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Tags: possible BLP issue or vandalism possible unreferenced addition to BLP
Line 16: Line 16:


==Criticism of psychiatry==
==Criticism of psychiatry==
A large portion of Lehmann's work concentrates on the [[iatrogenic]] (negative) effects of neuroleptics, the so-called [[antipsychotic]]s, argues that—similar like at [[alcohol (drug)|alcohol]]—in the medium and long term, the harmful effects (receptor-changes, deficit-syndrome, [[suicide|suicidality]], tardive [[psychosis]], tardive [[dyskinesia]], [[obesity]], [[hypercholesterolemia]], [[diabetes]], [[apoptosis]], etc.) typically outweigh short-time benefit, if a patient sees any benefit at all. Lehmann also argues that [[psychiatry]] as a medical discipline cannot do justice to the expectation of solving mental problems that are largely of a social nature; that its propensity to use [[involuntary treatment]] constitutes a threat; and that its diagnostic methods obstruct understanding of the real problems of individuals in society.
A large portion of Lehmann's work concentrates on the [[iatrogenic]] (negative, caused by therapy) effects of neuroleptics, the so-called [[antipsychotic]]s, argues that—similar like at [[alcohol (drug)|alcohol]]—in the medium and long term, the harmful effects (receptor-changes, deficit-syndrome, [[suicide|suicidality]], tardive [[psychosis]], tardive [[dyskinesia]], [[obesity]], [[hypercholesterolemia]], [[diabetes]], [[apoptosis]], etc.) typically outweigh short-time benefit, if a patient sees any benefit at all. Lehmann also argues that [[psychiatry]] as a medical discipline cannot do justice to the expectation of solving mental problems that are largely of a social nature; that its propensity to use [[involuntary treatment]] constitutes a threat; and that its diagnostic methods obstruct understanding of the real problems of individuals in society.


For these reasons, Lehmann pleads for developing adequate and effective assistance for people in emotional difficulty<ref name="MacklerMorrissey2010">{{cite book|last1=Mackler|first1=Daniel|last2=Morrissey|first2=Matthew|title=A Way Out of Madness: Dealing with Your Family After You've Been Diagnosed with a Psychiatric Disorder|url=https://books.google.com/books?id=85zVPI3NadcC&pg=PA30|accessdate=27 September 2011|date=2010-03-15|publisher=AuthorHouse|isbn=978-1-4490-8349-6|pages=30–}}</ref> and safeguarding their social inclusion. He advocates as well for their [[civil and political rights]] in treatment on a par with "normal" patients (which is also the position of the [[United_Nations|United Nations]]' [[Convention_on_the_Rights_of_Persons_with_Disabilities|Convention on the Rights of Persons with Disabilities]]), joining forces in cooperation with other [[human rights]] and [[support group]]s, and support in withdrawing from [[psychiatric drugs]]. He promotes the use of alternative and less toxic [[psychoactive drug]]s, an obstracization of electroshock (so-called [[electroconvulsive therapy]]) up to its ban, and new ways of living with madness and being different, with as much independence from institutions as possible, as well as tolerance, respect and appreciation of diversity at all levels of life.
For these reasons, Lehmann pleads for developing adequate and effective assistance for people in emotional difficulty<ref name="MacklerMorrissey2010">{{cite book|last1=Mackler|first1=Daniel|last2=Morrissey|first2=Matthew|title=A Way Out of Madness: Dealing with Your Family After You've Been Diagnosed with a Psychiatric Disorder|url=https://books.google.com/books?id=85zVPI3NadcC&pg=PA30|accessdate=27 September 2011|date=2010-03-15|publisher=AuthorHouse|isbn=978-1-4490-8349-6|pages=30–}}</ref> and safeguarding their social inclusion. He advocates as well for their [[civil and political rights]] in treatment on a par with "normal" patients (which is also the position of the [[United_Nations|United Nations]]' [[Convention_on_the_Rights_of_Persons_with_Disabilities|Convention on the Rights of Persons with Disabilities]]), joining forces in cooperation with other [[human rights]] and [[support group]]s, and support in withdrawing from [[psychiatric drugs]]. He promotes the use of alternative and less toxic [[psychoactive drug]]s, an obstracization of electroshock (so-called [[electroconvulsive therapy]]) up to its ban, and new ways of living with madness and being different, with as much independence from institutions as possible, as well as tolerance, respect and appreciation of diversity at all levels of life.

Revision as of 16:27, 6 March 2022

Peter Lehmann (2005)

Peter Lehmann (born 3 September 1950 in Calw, Black Forest, West Germany) is an author, social scientist, publisher, provider of a mail-order book-service and an independent freelance activist in humanistic anti-psychiatry, living in Berlin, Germany.

Overview

Peter Lehmann has an academic education in pedagogy. Since the 1970s, he has represented positions of humanistic anti-psychiatry within the consumer/survivor/ex-patient movement and circles of humanistic professionals.

In 1986, he founded Peter Lehmann Publishing and Mail-order Bookstore in Berlin and published his first book, Der chemische Knebel (The Chemical Gag) (Berlin: Antipsychiatrieverlag 1986) in German through his own Antipsychiatric Publishing House. In 2003, he founded a branch in United Kingdom and in 2004 in the United States of America.

In 1980, Peter Lehmann was co-founder of a support group of (ex-) users and survivors of psychiatry and advised about psychiatric drugs and withdrawal until 1989. In 1987, he was co-founder of PSYCHEX (Switzerland), an alliance of lawyers, doctors and survivors of psychiatry to support people who are incarcerated in psychiatric institutions); since then, board member. In 1989, he was co-founder of the Organization for the Protection from Psychiatric Violence (running the Runaway House Berlin, which opened its house for people seeking shelter from psychiatric violence in 1996).[1] Since 1990, Peter Lehmann has been co-editor of the Journal of Critical Psychology, Counselling and Psychotherapy (United Kingdom). In 1991, he was co-founder of the European Network of (ex-) Users and Survivors of Psychiatry (ENUSP) and was the organization’s chair from 1997–99[2] and was a board member until 2010. In 1997, he was co-founder of the World Network of Users and Survivors of Psychiatry (WNUSP). Since 2002, he has been a member of MindFreedom International and was its designated representative to the United Nations. In 2007, he was a member of the Organizational Committee of the Conference "Coercive Treatment in Psychiatry", run by the World Psychiatric Association in Dresden.[3]

Honors and awards

In 2010, Peter Lehmann was awarded an honorary doctorate in acknowledgment of "exceptional scientific and humanitarian contribution to the rights of the people with psychiatric experience" by the School of Psychology of the Aristotle University of Thessaloniki, Greece, Philosophical Faculty. Kostas Bairaktaris, Prof. of Clinical Psychology, gave the speech in Peter Lehmann's honor. Lehmann is the first survivor of psychiatry in the world to be honored with an honorary degree for pioneering achievements within the realm of humanistic anti-psychiatry.[4] In 2011, he was awarded the Order of Merit of the Federal Republic of Germany in acknowledgement of service to the community by the President of Germany.[5]

Criticism of psychiatry

A large portion of Lehmann's work concentrates on the iatrogenic (negative, caused by therapy) effects of neuroleptics, the so-called antipsychotics, argues that—similar like at alcohol—in the medium and long term, the harmful effects (receptor-changes, deficit-syndrome, suicidality, tardive psychosis, tardive dyskinesia, obesity, hypercholesterolemia, diabetes, apoptosis, etc.) typically outweigh short-time benefit, if a patient sees any benefit at all. Lehmann also argues that psychiatry as a medical discipline cannot do justice to the expectation of solving mental problems that are largely of a social nature; that its propensity to use involuntary treatment constitutes a threat; and that its diagnostic methods obstruct understanding of the real problems of individuals in society.

For these reasons, Lehmann pleads for developing adequate and effective assistance for people in emotional difficulty[6] and safeguarding their social inclusion. He advocates as well for their civil and political rights in treatment on a par with "normal" patients (which is also the position of the United Nations' Convention on the Rights of Persons with Disabilities), joining forces in cooperation with other human rights and support groups, and support in withdrawing from psychiatric drugs. He promotes the use of alternative and less toxic psychoactive drugs, an obstracization of electroshock (so-called electroconvulsive therapy) up to its ban, and new ways of living with madness and being different, with as much independence from institutions as possible, as well as tolerance, respect and appreciation of diversity at all levels of life.

Publications

Coming off Psychiatric Drugs: Successful Withdrawal from Neuroleptics, Antidepressants, Lithium, Carbamazepine and Tranquilizers (2004) was originally published in German in 1998 and was the first book on this issue world-wide. Beside family members and professionals, Lehmann primarily addresses people who choose to withdraw from these drugs. He shows detailed accounts of how others came off these substances without once again ending up in the doctor's office. Beside people from different countries all over the world, in his practice book professionals, working in psychotherapy, medicine, psychiatry, social work, naturopathy and alternative places, report on how they helped in the withdrawal process. This book is also published in Greek, French and Spanish.

In his second English book, Alternatives beyond psychiatry, co-edited in 2007 with psychiatrist Peter Stastny, Lehmann highlights alternatives beyond psychiatry, current possibilities of self-help for individuals experiencing madness, and strategies towards implementing humane treatment. Also published in the German, Greek and Marathi.

In his latest book, Withdrawal from Prescribed Psychotropic Drugs, co-edited in 2021 with psychologist Craig Newnes, Lehmann presents a collaboration of professionals in the psychosocial field, researchers, lawyers, and ex-patients around the world (the Global South included) committed to helping people understand the potential harm (including drug dependence) that prescribed psychotropic drugs can cause, based on the latest research findings, and how to reduce or stop taking them with less risks.

Bibliography

Books

  • Lehmann, P. (Ed.) (2004), Coming off Psychiatric Drugs: Successful withdrawal from neuroleptics, antidepressants, lithium, carbamazepine and tranquilizers. ISBN 978-0-9545428-0-1 (U.K.), ISBN 978-0-9788399-0-1 (USA). Berlin / Eugene / Shrewsbury: Peter Lehmann Publishing. Ebook editions in 2018.
  • Stastny, P. & Lehmann, P. (Eds.) (2007), Alternatives beyond Psychiatry. ISBN 978-0-9545428-1-8 (U.K.), ISBN 978-0-9788399-1-8 (USA). Berlin / Eugene / Shrewsbury: Peter Lehmann Publishing. Ebook editions in 2018.

Selected articles

  • Lehmann, P. (2019). Paradigm shift: Treatment alternatives to psychiatric drugs, with particular reference to low- and middle-income countries. In: L. Davidson (Ed.), The Routledge Handbook of International Development, Mental Health and Wellbeing (pp.  251-269). London / New York: Routledge ISBN 978-0-367-02773-5.
  • Lehmann, P. (2019). Transparency first. Disclosure of conflicts of interest in the psychiatric field. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 19(2), 131-151.
  • Lehmann, P. (2018). Teaching withdrawal of antipsychotics and antidepressants to professionals and recipients. In: C. Newnes / L. Golding (Eds.), Teaching Critical Psychology: International perspectives (pp. 148-169). Abingdon / New York: Routledge ISBN 978-1-138-28833-1.
  • Lehmann, P. (2015). Are users and survivors of psychiatry only allowed to speak about their personal narratives?. In: J.Z. Sadler, K.W.M. Fulford, & C.W. Van Staden (Eds.), The Oxford Handbook of Psychiatric Ethics, Vol. 1 (pp. 98-104). Oxford: Oxford University Press ISBN 978-0-19-966388-0.
  • Lehmann, P. (2015). Securing human rights in the psychiatric field by advance directives. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 15(1), 1-10.
  • Lehmann, P. (2014). Facebook friends and other enemies. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 14(1), 37-43.
  • Lehmann, P. (2014). Two contradictory sides of recovery and psychosocial rehabilitation. E-bulletin of the World Association for Psychosocial Rehabilitation) (Madrid), (35), 7-12.
  • Lehmann, P. (2013). Early warning signs of chronic or lethal diseases due to the administration of neuroleptics. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 13(1), 23-29.
  • Lehmann, P. (2013). Me and Thomas Szasz. Contrarian approaches to anti-psychiatry. Asylum–The Magazine for Democratic Psychiatry (U.K.), 20(2), 12.
  • Lehmann, P. (2012). About the intrinsic suicidal effects of neuroleptics: Towards breaking the taboo and fighting therapeutical recklessness. International Journal of Psychotherapy, 16(1), 30-49.
  • Lehmann, P. (2010). The particular elements of Soteria from the perspective of (ex-) users and survivors of psychiatry. Asylum–The Magazine for Democratic Psychiatry (U.K.), 17(4), 11-13.
  • Lehmann, P. (2010). How to withdraw from psychiatric drugs. Asylum–The Magazine for Democratic Psychiatry (U.K.), 17(2), 29-31.
  • Lehmann, P. (2010). Medicalization and irresponsibility. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 10(4), 209-217.
  • Lehmann, P. (2010). International noncompliance and humanistic antipsychiatry. In K. Bairaktaris (Ed.), Proceedings of the European Congress against Discrimination and Stigma, for User-Orientated Reforms in Psychiatry and the Right to Alternatives (pp. 63-72). Thessaloniki: Aristotle University of Thessaloniki ISBN 978-960-88503-5-4.
  • Lehmann, P. (2010). Resisting psychiatric assault: A European initiative to introduce a suicide register. In B. Burstow & S. Diamond (Eds.), Proceedings of the PsychOUT-conference, May 7–8, 2010. Toronto: Ontario Institute for Studies in Education, University of Toronto 2010.
  • Lehmann, P. (2009). Variety instead of stupidity: About the different positions within the movement of (ex-) users and survivors of psychiatry. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 9(4), 197-204.
  • Lehmann, P. (2007). From the madhouse to the warmth of others. aaina—A mental health advocacy newsletter (India), 7(3), 9-12.
  • Lehmann, P. (2005). All about PSY DREAM: Psychiatric drug registration, evaluation and all-inclusive monitoring. Epidemiologia e Psichiatria Sociale, 14(1), 15-21.
  • Lehmann, P. (2002). Treatment-induced suicide: Suicidality as a potential effect of psychiatric drugs. Journal of Critical Psychology, Counselling and Psychotherapy (U.K.), 2(1), 54-58.
  • Lehmann, P. (2001). Coming off neuroleptics. In C. Newnes, G. Holmes & C. Dunn (Eds.), This is Madness Too: Critical perspectives on mental health services (pp. 81-91). Ross-on-Wye: PCCS Books ISBN 978-1-898059-37-0.
  • Lehmann, P. (2000). Manage or perish? Or choosing to live without neuroleptic drugs? In J. Guimón & N. Sartorius (Eds.), Manage or Perish? The challenges of managed mental health care in Europe (pp. 469-474). New York / Boston / Dordrecht / London / Moscow: Kluwer Adacemic / Plenum Publishers ISBN 978-0-306-46210-8.
  • Lehmann, P. (1999). Promotion of mental health and prevention of mental disorders by empowerment: Is there a psychiatry-policy without meaningful participation of (ex-) users/survivors of psychiatry? In J. Lavikainen, E. Lahtinen & V. Lehtinen (Eds.), Proceedings of the European Conference on Promotion of Mental Health and Social Inclusion, 10–13 October 1999, Tampere, Finland (pp. 108-110). Helsinki: Ministry of Social Affairs and Health ISBN 952-00-0896-9.
  • Lehmann, P. (1999). Psychiatric emergency-treatment: Help against one's will or action of professional violence? In M. De Clercq, A. Andreoli, S. Lamarre & P. Forster (Eds.), Emergency Psychiatry in a Changing World: Proceedings of the 5th World Congress of the International Association for Emergency Psychiatry (pp. 95-104). Amsterdam / Lausanne / New York / Oxford / Shannon / Singapore / Tokyo: Elsevier ISBN 978-0-444-50017-5.
  • Lehmann, P. (1998). Perspectives of (ex-) users and survivors of psychiatry. In E. Lahtinen (Ed.), Mental Health Promotion on the European Agenda. Report from a Consultative Meeting, 15–16 January 1998, Helsinki, Finland (pp. 63-68). Helsinki: STAKES Publications.
  • Lehmann, P. (1998). Remarks and points to be added to the Declaration of Madrid (World Psychiatric Association). In The Voiceless Movement / Les Sans-Voix (Ed.), Deprived of Our Humanity: The case against neuroleptic drugs (pp. 159-162). Geneva: Association Ecrivains, Poètes & Cie. ISBN 978-2-88462-039-0.
  • Lehmann, P. (1998). Withdrawal symptoms connected with cessation of psychiatric drugs. In The Voiceless Movement / Les Sans-Voix (Ed.), Deprived of Our Humanity: The case against neuroleptic drugs (pp. 73-80). Geneva: Association Ecrivains, Poètes & Cie. ISBN 978-2-88462-039-0.
  • Lehmann, P. (1994). "Progressive" psychiatry: Publisher J. F. Lehmann as promoter of social psychiatry under fascism. Changes–An International Journal of Psychology and Psychotherapy (U.K.), 12(1), 37-49.
  • Lehmann, P. & Kempker, K. (1993). Unconventional approaches to psychiatry. Clinical Psychology Forum (U.K.), (51), 28-29.

References